Geneos Wealth Management’s American Healthcare REIT AHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
27,271
+2,285
+9% +$112K 0.03% 460
2026
Q1
$1.18M Hold
24,986
– – 0.03% 469
2025
Q4
$1.18M Sell
24,986
-972
-4% -$45.1K 0.03% 461
2025
Q3
$1.09M Sell
25,958
-5,625
-18% -$226K 0.03% 463
2025
Q2
$1.16M Buy
31,583
+8,218
+35% +$273K 0.03% 497
2025
Q1
$708K Sell
23,365
-3,315
-12% -$95.6K 0.02% 525
2024
Q4
$758K Buy
+26,680
New +$718K 0.03% 482

Other funds holding AHR

Geneos Wealth Management's AHR Position: Q2 2026 in Review

Geneos Wealth Management increased its American Healthcare REIT (AHR) stake by 9.1% in Q2 2026, buying an estimated $112K and bringing the position to 27,271 shares worth $1.42M. The position accounts for 0.03% of the portfolio, ranked #460.

Geneos Wealth Management first reported a position in AHR in Q4 2024 and has held it in 7 quarters since. 573 funds tracked by Wall St. Rank hold AHR as of Q2 2026.

  • Geneos Wealth Management held 27,271 shares of American Healthcare REIT worth $1.42M as of Q2 2026.
  • Geneos Wealth Management bought 2,285 American Healthcare REIT shares in Q2 2026, an estimated $112K.
  • American Healthcare REIT made up 0.03% of Geneos Wealth Management's portfolio in Q2 2026, its #460 holding.
  • Geneos Wealth Management first reported a position in American Healthcare REIT in Q4 2024 and has held it in 7 quarters since.
  • 573 funds tracked by Wall St. Rank held American Healthcare REIT as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.